Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Short-term Investments: 2023-2024

Historic Short-term Investments for Centessa Pharmaceuticals (CNTA) over the last 2 years, with Dec 2024 value amounting to $99.0 million.

  • Centessa Pharmaceuticals' Short-term Investments rose 58.32% to $195.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $195.4 million, marking a year-over-year increase of 58.32%. This contributed to the annual value of $99.0 million for FY2024, which is 23.00% down from last year.
  • Per Centessa Pharmaceuticals' latest filing, its Short-term Investments stood at $99.0 million for FY2024, which was down 23.00% from $128.5 million recorded in FY2023.
  • In the past 5 years, Centessa Pharmaceuticals' Short-term Investments registered a high of $128.5 million during FY2023, and its lowest value of $99.0 million during FY2024.
  • Its 2-year average for Short-term Investments is $113.7 million, with a median of $113.7 million in 2023.
  • Data for Centessa Pharmaceuticals' Short-term Investments shows a maximum YoY decreased of 23.00% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Centessa Pharmaceuticals' Short-term Investments stood at $128.5 million in 2023, then declined by 23.00% to $99.0 million in 2024.